World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
85
Citations
34223
World Ranking
14427
National Ranking
7299

Overview

Steven Galetta is affiliated with New York University Langone Medical Center in the United States. Their primary field of research is Medicine, with a strong focus on Neurology, supported by 252 publications in this subfield. Additional research interests include Epidemiology, Ophthalmology, Psychiatry and Mental Health, and Pathology and Forensic Medicine.

Their recent research output includes several papers addressing neurological complications related to COVID-19 and other neurovascular conditions. These include:

  • A Prospective Study of Neurologic Disorders in Hospitalized Patients With COVID-19 in New York City (2020, Neurology)
  • A prospective study of long-term outcomes among hospitalized COVID-19 patients with and without neurological complications (2021, Journal of the Neurological Sciences)
  • Hemorrhagic stroke and anticoagulation in COVID-19 (2020, Journal of Stroke and Cerebrovascular Diseases)
  • COVID-19 related neuroimaging findings: A signal of thromboembolic complications and a strong prognostic marker of poor patient outcome (2020, Journal of the Neurological Sciences)
  • Optic neuritis and autoimmune optic neuropathies: advances in diagnosis and treatment (2022, The Lancet Neurology)

Steven Galetta has co-authored extensively with a number of researchers, highlighting collaborative work in their field. Frequent co-authors include:

  • Ariane Lewis
  • Aravind Ganesh
  • James E. Siegler
  • Laura J. Balcer
  • Scott N. Grossman

The venues where Steven Galetta has published regularly demonstrate a focus on neurological sciences and neuro-ophthalmology. Common publication venues are:

  • Neurology
  • Journal of Neuro-Ophthalmology
  • Journal of the Neurological Sciences
  • Neurology Neuroimmunology & Neuroinflammation
  • bioRxiv (Cold Spring Harbor Laboratory)

Their research addresses several key topics within neurology and related disorders, including:

  • Acute Ischemic Stroke Management
  • Long-Term Effects of COVID-19
  • Multiple Sclerosis Research Studies
  • Traumatic Brain Injury and Neurovascular Disturbances
  • Retinal and Optic Conditions
  • Peripheral Neuropathies and Disorders
  • Epilepsy research and treatment

Steven Galetta's work spans acute neurological disorder management, long-term neurological outcomes post-infection, neuroimaging markers of disease, and both clinical and research aspects of neuro-ophthalmology and neurovascular conditions. Their research contributions are situated within the context of ongoing global health challenges such as the COVID-19 pandemic, emphasizing neurological impact and treatment considerations.

Best Publications

  • Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria

    Alan J. Thompson;Brenda L. Banwell;Frederik Barkhof;Frederik Barkhof;William M. Carroll

  • Natalizumab plus Interferon Beta-1a for Relapsing Multiple Sclerosis

    Richard A. Rudick;William H. Stuart;Peter A. Calabresi;Christian Confavreux

  • Differential diagnosis of suspected multiple sclerosis: a consensus approach

    D. H. Miller;B. G. Weinshenker;M. Filippi;B. L. Banwell

  • Relation of Visual Function to Retinal Nerve Fiber Layer Thickness in Multiple Sclerosis

    Jennifer B. Fisher;Dina A. Jacobs;Clyde E. Markowitz;Steven L. Galetta

  • Treatment-responsive limbic encephalitis identified by neuropil antibodies: MRI and PET correlates

    Beau M. Ances;Roberta Vitaliani;Robert A. Taylor;Robert A. Taylor;David S. Liebeskind;David S. Liebeskind

  • The neuro-ophthalmology of multiple sclerosis

    E.M. Frohman;T.C. Frohman;D.S. Zee;R. McColl

  • Longitudinal study of vision and retinal nerve fiber layer thickness in multiple sclerosis.

    Lauren S. Talman;Esther R. Bisker;David J. Sackel;David A. Long

  • Effect of natalizumab on clinical and radiological disease activity in multiple sclerosis: a retrospective analysis of the Natalizumab Safety and Efficacy in Relapsing-Remitting Multiple Sclerosis (AFFIRM) study

    Eva Havrdova;Steven Galetta;Michael Hutchinson;Dusan Stefoski

  • The incidence and significance of anti-natalizumab antibodies: Results from AFFIRM and SENTINEL

    P. A. Calabresi;G. Giovannoni;C. Confavreux;S. L. Galetta

  • The King-Devick test and sports-related concussion: study of a rapid visual screening tool in a collegiate cohort.

    Kristin M. Galetta;Lauren E. Brandes;Karl Maki;E. Mark S. Dziemianowicz

  • Multiple sclerosis: gadolinium enhancement in MR imaging.

    R I Grossman;F Gonzalez-Scarano;S W Atlas;S Galetta

  • MRI findings in Susac’s syndrome

    John O. Susac;F. R. Murtagh;R. A. Egan;J. R. Berger

  • The King-Devick test as a determinant of head trauma and concussion in boxers and MMA fighters

    K. M. Galetta;J. Barrett;Mike Allen;F. Madda

  • Ganglion cell loss in relation to visual disability in multiple sclerosis.

    Scott D. Walter;Hiroshi Ishikawa;Kristin M. Galetta;Reiko E. Sakai

  • Profiles of Obesity, Weight Gain, and Quality of Life in Idiopathic Intracranial Hypertension (Pseudotumor Cerebri)

    Anthony B. Daniels;Grant T. Liu;Nicholas J. Volpe;Steven L. Galetta

  • The efficacy of natalizumab in patients with relapsing multiple sclerosis: subgroup analyses of AFFIRM and SENTINEL

    M. Hutchinson;L. Kappos;P. A. Calabresi;C. Confavreux

  • The utility of MRI in suspected MS: report of the Therapeutics and technology assessment Subcommittee of the American Academy of Neurology

    EM Frohman;DS Goodin;PA Calabresi;JR Corboy

  • Macular Volume Determined by Optical Coherence Tomography as a Measure of Neuronal Loss in Multiple Sclerosis

    Bryn M. Burkholder;Bryn M. Burkholder;Benjamin Osborne;Benjamin Osborne;Michael J. Loguidice;Esther Bisker

  • Safety and efficacy of opicinumab in acute optic neuritis (RENEW): a randomised, placebo-controlled, phase 2 trial

    Diego Cadavid;Laura Balcer;Steven Galetta;Orhan Aktas

  • The Clinical Spectrum of Unruptured Intracranial Aneurysms

    E. C. Raps;J. D. Rogers;S. L. Galetta;R. A. Solomon

Frequent Co-Authors

Laura J. Balcer
Laura J. Balcer New York University
Peter A. Calabresi
Peter A. Calabresi Johns Hopkins University School of Medicine
Robert I. Grossman
Robert I. Grossman New York University
Maureen G. Maguire
Maureen G. Maguire University of Pennsylvania
Elliot M. Frohman
Elliot M. Frohman The University of Texas at Austin
Murray Grossman
Murray Grossman University of Pennsylvania
Abass Alavi
Abass Alavi University of Pennsylvania
Scott E. Kasner
Scott E. Kasner University of Pennsylvania
Josep Dalmau
Josep Dalmau University of Barcelona
Gary Cutter
Gary Cutter University of Alabama at Birmingham

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Medicine in the USA offers more than traditional medical degrees—there are also numerous allied health and nursing pathways that can fast-track your career. Online degrees have become popular options, providing flexibility for working professionals and those looking to shift careers.

For advanced nursing roles, exploring dnp programs online can help you attain a Doctor of Nursing Practice degree at your own pace. Those seeking a less demanding path might consider the easiest dnp program online to minimize workload while still advancing their qualifications.

Not quite ready for a graduate degree? Starting as a practical nurse is an accessible entry point—look into fast track lpn programs, which provide the quickest route to hands-on patient care. For those already holding a nursing bachelor’s degree, direct progression is possible with bsn to np programs online, offering a swift transition into nurse practitioner roles, including specialties like mental health.

Each online pathway presents unique advantages depending on your current education, goals, and desired time to enter the workforce.

Best Scientists Citing Steven Galetta

Trending Scientists